Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.74 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.68 |
| ▸ | MET | P08581 | 8/20 | 0.66 |
| ▸ | CA12 | O43570 | 4/20 | 0.66 |
| ▸ | CA4 | P22748 | 4/20 | 0.66 |
| ▸ | CA6 | P23280 | 4/20 | 0.66 |
| ▸ | CA5A | P35218 | 4/20 | 0.66 |
| ▸ | CA7 | P43166 | 4/20 | 0.66 |
| ▸ | CA9 | Q16790 | 4/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.66 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.64 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119037 | 1.00 | MAOB (0.74) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL12731809 | 0.96 | MAOB (0.69) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL12731782 | 0.94 | MAOB (0.66) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL12731783 | 0.94 | CA12 (0.69) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL16838237 | 0.94 | MAOB (0.70) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL10075931 | 0.94 | MAOB (0.69) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL2120658 | 0.94 | MAOB (0.69) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL2118579 | 0.92 | MAOB (0.74) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL18993838 | 0.90 | MAOB (0.74) | MAOBEPHX2METCA12CA4 | |
| SCHEMBL7794444 | 0.90 | MAOB (0.74) | MAOBEPHX2METCA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104886-A1 | METHOD FOR EXTRACTING LOW-MOLECULAR WEIGHT COLLAGEN USING POLLACK SKIN, LOW-MOLECULAR WEIGHT COLLAGEN, AND COSMETIC COMPOSITION COMPRISING SAME WITH SKIN REGENERATION EFFICACY | 유엔케이코리아 주식회사 | 2026-05-21 | — | — | WO | disclosed |
| US-12350352-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2025-07-08 | — | — | US | disclosed |
| CN-119639835-A | Preparation method of keemun camellia seed fermented oil | 广州中妆美业化妆品有限公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024234021-A2 | CONJUGATE AND COMPOSITION FOR TREATING CANCER | STELLENBOSCH UNIVERSITY (ZA) | 2024-11-14 | — | — | WO | disclosed |
| EP-3342395-B1 | COMPOSITION FOR HAIR SURFACE MODIFICATION | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2024-08-07 | — | — | EP | disclosed |
| EP-4406617-A2 | COMPOSITION FOR SURFACE MODIFICATION | LG Household & Health Care Ltd. (KR) | 2024-07-31 | — | — | EP | disclosed |
| US-11612552-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. | 2023-03-28 | — | — | US | disclosed |
| US-20230088314-A1 | Composition For Surface Modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| WO-2022114681-A1 | CLEANSER COMPOSITION WITH ENHANCED ACTIVE SUBSTANCE DELIVERY | 주식회사 엘지생활건강 | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12350352-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | MAOB 2221/4885EPHX2 2569/4885MET 269/4885 |
| US-20230088314-A1 | Composition For Surface Modification | CUTA, PTMS, DNMT1 | MAOB 2221/4885EPHX2 2569/4885MET 269/4885 |
| US-11612552-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | MAOB 2221/4885EPHX2 2569/4885MET 269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.